Evidence of pulpotomy in primary teeth comparing MTA, calcium hydroxide, ferric sulphate, and electrosurgery with formocresol

Aeinehchi M, Dadvand S, Fayazi S, Bayat-Movahed S. Randomized controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth. Int Endod J. 2007;40:261–7.

Agamy HA, Bakry NS, Mounir MM, Avery DR. Comparison of mineral trioxide aggregate and formocresol as pulp-capping agents in pulpotomized primary teeth. Pediatr Dent. 2004;26:302–9.

Agell RS. Clinical and radiographic evaluation of primary molars with necrotic pulp treated with two formocresol concentrations. Acta Odontol Venez. 1989;27:3–9.

Alaçam A, Odabas ME, Tüzüner T, Sillelioglu H, Baygin O. Clinical and radiographic outcomes of calcium hydroxide and formocresol pulpotomies performed by dental students. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:e127–33.

American Academy of Pediatric Dentistry (AAPD). Guideline on pulp therapy for primary and immature permanent tooth. Clinical guidelines—reference manual 2012–2013. Pediatr Dent. 2012;34:222–9.

Ansari G, Ranjpour M. Mineral trioxide aggregate and formocresol pulpotomy of primary teeth: a 2-year follow-up. Int Endod J. 2010;43:413–8.

Anthonappa RP, King NM, Martens LC. Is there sufficient evidence to support the long-term efficacy of mineral trioxide aggregate (MTA) for endodontic therapy in primary teeth. Int Endod J. 2013;46:198–204.

Bahrololoomi Z, Moeintaghavi A, Emtiazi M, Hosseini GA. Clinical and radiographic comparison of primary molars after formocresol and electrosurgical pulpotomy: a randomized clinical trial. Indian J Dent Res. 2008;19:219–23.

Bergoli AD, Primosch RE, de Araujo FB, Ardenghi TM, Casagrande L. Pulp therapy in primary teeth—profile of teaching in Brazilian dental schools. J Clin Pediatr Dent. 2010;35:191–5.

Bowen JL, Math-Muju K, Nash DA, et al. Pediatric and general dentists’ attitudes toward pulp therapy for primary teeth. Pediatric Dent. 2012;34:210–5.

De Coster P, Rajasekharan S, Martens L. Laser-assisted pulpotomy in primary teeth: a systematic review. Int J Paediatr Dent. 2013;23:389–99.

Dean JA, Mack RB, Fulkerson BT, Sanders BJ. Comparison of electrosurgical and formocresol pulpotomy procedures in children. Int J Paediatr Dent. 2002;12:177–82.

Dunston B, Coll JA. A survey of primary tooth pulp therapy as taught in US dental schools and practiced by diplomates of the American Board of Pediatric Dentistry. Pediatr Dent. 2008;30:42–8.

Eidelman E, Holan G, Fuks AB. Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatr Dent. 2001;23:15–8.

Elkhadem A, Nagi P. Effectiveness of MTA pulpotomy in primary molars: a clinical assessment of relevant studies. Evid Based Dent. 2013;14:46.

Erdem AP, Guven Y, Balli B, et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24-month study. Pediatr Dent. 2011;33:165–70.

Fernandez CC, Martinez SS, Jimeno FG, Rodrigues AIL, Mercade M. Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2-year follow-up. Int J Paediatr Dent. 2013;23:400–7.

Fornetti APC, Lourenço Neto N, Moretti ABS, et al. Clinical and radiographic study on 1/5 dilution of Buckley’s formocresol and Portland cement used for pulpotomies of human primary teeth. Rev Odontol UNESP. 2009;38:161–8.

Fuks AB, Holan G, Davis JM, Eidelman E. Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long-term follow up. Pediatr Dent. 1997;19:327–30.

Ghajari MF, Kermani NM, Fard MJK, Vantanpour M. Comparison of formocresol and ferric sulfate pulpotomy in primary molars: a systematic review and meta-analysis. J Den (Tehran). 2009;6:29–36.

Godhi B, Sood PB, Sharma A. Effects of mineral trioxide aggregate and formocresol on vital pulp after pulpotomy of primary molars: an in vivo study. Contemp Clin Dent. 2011;2:296–301.

Golpayegani MV, Ansari G, Tadayon N, Shams SH, Mir M. Low-level laser therapy for pulpotomy treatment of primary molars. J Den (Tehran). 2009;6:168–74.

Hincapié S, Fuks A, Mora I, Bautista G, Socarras F. Teaching and practical guidelines in pulp therapy in primary teeth in Colombia–South America. Int J Paediatr Dent. 2014. doi: 10.1111/ipd.12103 .

Holan G, Eidelman E, Fuks AB. Long-term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatr Dent. 2005;27:129–36.

Hugar SM, Deshpande SD. Comparative investigation of clinical/radiographical signs of mineral trioxide aggregate and formocresol on pulpotomized primary molars. Contemp Clin Dent. 2010;1:146–51.

Huth KC, Al-Khatar NH, Wolf P, et al. Long-term effectiveness of four pulpotomy techniques: 3 year randomized controlled trial. Clin Oral Investig. 2012;16:1243–50.

Huth KC, Paschos E, Hajek-Al-Khatar N, et al. Effectiveness of 4 pulpotomy techniques-randomized controlled trial. J Dent Res. 2005;84:1144–8.

Ibricevic H, Al-Jame Q. Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow-up. J Clin Pediatr Dent. 2000;24:269–72.

Ibricevic H, Al-Jame Q. Ferric sulfate and formocresol in pulpotomy of primary molars: long term follow-up study. Eur J Paediatr Dent. 2003;4:28–32.

Jabbarifar SE, Khademi AA, Ghasemi D. Success rate of formocresol pulpotomy versus mineral trioxide aggregate in human primary molar tooth. J Res Med Sci. 2004;9:304–7.

Khorakian F, Mazhari F, Asgary S, et al. Two-year outcomes of electrosurgery and calcium-enriched mixture pulpotomy in primary teeth: a randomized clinical trial. Eur Arch Paediatr Dent. 2014;15:223–8.

Leon RR, Steele PJ, Jeansonne BG. Ferric sulfate hemostasis. Effect on osseous wound healing left in situ for maximum exposure. J Endod. 1993;19:170–3.

Lin PY, Chen HS, Wang YH, Tu YK. Primary molar pulpotomy: a systematic review and network meta-analysis. J Dent. 2014;42:1060–77.

Liu JF. Effects of Nd: YAG laser pulpotomy on human primary molars. J Endod. 2006;32:404–7.

Loh A, O’Hoy P, Tran X, et al. Evidence-based assessment: evaluation of the formocresol versus ferric sulfate primary molars pulpotomy. Pediatr Dent. 2004;26:401–9.

Markovic D, Zivojinovic V, Vucetic M. Evaluation of three pulpotomy medicaments in primary teeth. Eur J Paediatr Dent. 2005;6:133–8.

Mickenautsch S, Yengopal JV, Bonecker M, et al. Minimum intervention: a new approach in dentistry. 1st ed. Houghton: Midentistry corp; 2006.

Moretti AB, Sakai VT, Oliveira TM, et al. The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth. Int Endod J. 2008;41:547–55.

Naik S, Hegde A. Mineral trioxide aggregate as a pulpotomy agent in primary molars: an in vivo study. J Indian Soc Pedod Prev Dent. 2005;23:13–6.

Neamatollahi H, Tajik A. Comparison of clinical and radiographic success rates of pulpotomy in primary molars using formocresol, ferric sulfate and mineral trioxide aggregate (MTA). J Den (Tehran). 2006;3:6–14.

Ng FK, Messer LB. Mineral trioxide aggregate as a pulpotomy medicament: an evidence-based assessment. Eur Arch Paediatr Dent. 2008;9:58–73.

Ni Chaollai A, Monteiro J, Duggal MS. The teaching of management of the pulp in primary molars in Europe. A preliminary investigation in Ireland and the UK. Eur Arch Paediatr Dent. 2009;10:98–103.

Noorollahian H. Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars. Br Dent J. 2008;204:E20.

Odabas ME, Bodur H, Baris E, Demir C. Clinical, radiographic, and histopathologic evaluation of Nd: YAG laser pulpotomy on human primary teeth. J Endod. 2007;33:415–21.

Papagiannoulis L. Clinical studies on ferric sulphate as a pulpotomy medicament in primary teeth. Eur J Paediatr Dent. 2002;3:126–32.

Peng L, Ye L, Tan H, Zhou X. Evaluation of the formocresol versus mineral trioxide aggregate primary molar pulpotomy: a meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:e40–4.

Peng L, Ye L, Guo X, Tan H, Zhou X, Wang C, Li R. Evaluation of formocresol versus ferric sulphate primary molar pulpotomy: a systematic review and meta-analysis. Int End J. 2007;40:751–7.

Ranly DM, Garcia-Godoy F. Reviewing pulp treatment for primary teeth. J Am Dent Assoc. 1991;122:83–6.

Ranly DM. Pulpotomy therapy in primary teeth: new modalities for old rationales. Pediatr Dent. 1994;16:403–9.

Rivera N, Reyes E, Mazzaoui S, Morón A. Pulpal therapy for primary teeth: formocresol vs electrosurgery: a clinical study. J Dent Child (Chic). 2003;70:71–3.

Sabbarini J, Mohamed A, Wahba N, El-Meligy O, Dean J. Comparison of enamel matrix derivative versus formocresol as pulpotomy agents in the primary dentition. J Endod. 2008;34:284–7.

Sano JT, Valdivieso MVM. Estudio comparativo, clínico radiográfico del sulfato férrico (15.5 %) y formocresol (Fórmula de Buckley) en pulpotomías de molares deciduas: resultados a 12 meses. Odont Pediatr. 2002;1:17–22.

Shirvani A, Asgary S. Mineral trioxide aggregate versus formocresol pulpotomy: a systematic review and meta-analysis of randomized clinical trials. Clin Oral Investig. 2014;18:1023–30.

Simancas-Pallares MA, Díaz-Caballero AJ, Luna-Ricardo LM. Mineral trioxide aggregate in primary teeth pulpotomy. A systematic literature review. Med Oral Patol Oral Cir Bucal. 2010;15:942–6.

Smaïl-Faugeron V, Courson F, Durieux P, et al. Pulp treatment for extensive decay in primary teeth. Cochrane Database Syst Rev. 2014;8:CD003220. doi: 10.1002/14651858.CD003220.pub2 .

Sonmez D, Sari S, Cetinbas T. A Comparison of four pulpotomy techniques in primary molars: a long-term follow-up. J Endod. 2008;34:950–5.

Srinivasan D, Jayanthi M. Comparative evaluation of formocresol and mineral trioxide aggregate as pulpotomy agents in deciduous teeth. Indian J Dent Res. 2011;22:385–90.

Subramaniam P, Konde S, Mathew S, Sugnani S. Mineral trioxide aggregate as pulp capping agent for primary teeth pulpotomy: 2 year follow up study. J Clin Pediatr Dent. 2009;33:311–4.

Sushynski JM, Zealand CM, Botero TM, Boynton JR, Majewski RF, Shelburne CE, Hu JC. Comparison of gray mineral trioxide aggregate and diluted formocresol in pulpotomized primary molars: a 6- to 24-month observation. Pediatric Dent. 2012;34:120e–128e.

Waterhouse PJ, Nunn JH, Whitworth JM. Formocresol pulpotomy an investigation of the relative efficacy of Buckley’s Formocresol and calcium hydroxide in primary molar vital pulp therapy. Br Dent J. 2000;188:32–6.

Zealand CM, Briskie DM, Botero TM, Boynton JR, Hu JC. Comparing gray mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars. Pediatr Dent. 2010;32:393-9.

Zurn D, Seale NS. Light-cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial. Pediatr Dent. 2008;30:34–41.